期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Funding Cuts Create Chaos in Global Health Programs
1
作者 Mitch Leslie 《Engineering》 2025年第11期3-6,共4页
The drug lenacapavir(Yeztugo®;Gilead Sciences,USA),which targets the human immunodeficiency virus(HIV),has been hailed as“revolutionary,”“a miracle,”and“the most transformative prevention product we have had... The drug lenacapavir(Yeztugo®;Gilead Sciences,USA),which targets the human immunodeficiency virus(HIV),has been hailed as“revolutionary,”“a miracle,”and“the most transformative prevention product we have had in 44 years”of the HIV pandemic.Although other drugs can stop HIV transmission,people typically must take a pill every day(Fig.1)[1]. 展开更多
关键词 lenacapavir globalhealthprograms fundingcuts humanimmunodeficiencyvirus HIV gileadsciences human immunodeficiency virus hiv yeztugo
暂未订购
上一页 1 下一页 到第
使用帮助 返回顶部